| MiRNA | Compound | Condition | Effect | Throughput | PMID | Details |
|---|---|---|---|---|---|---|
| miR-99b | Cisplatin | ovarian cancer | Resistant | High | 19237188 | |
| miR-92a-2* | Cisplatin | small cell lung cancer | Resistant | Low | 20548249 | |
| miR-923 | Cisplatin | germ cell tumor | Resistant | High | 21575166 | |
| miR-935 | Cisplatin | germ cell tumor | Resistant | High | 21575166 | |
| miR-99a | Cisplatin | germ cell tumor | Sensitive | High | 21575166 | |
| miR-96 | Cisplatin | ehrlich ascites tumor | Resistant | High | 21899346 | |
| miR-93 | Cisplatin | ovarian cancer | Resistant | Low | 22465665 | |
| miR-92a | Cisplatin | ovarian cancer | Resistant | High | 22614869 | |
| miR-98 | Cisplatin | ovarian cancer | Resistant | High | 22614869 | |
| miR-99a | Cisplatin | ovarian cancer | Resistant | High | 22614869 | |
| miR-96 | Cisplatin | cancer | Sensitive | Low | 22761336 | |
| miR-96 | Cisplatin | esophageal squamous cell carcinoma | Sensitive | High | 22847808 | |
| miR-99a | Cisplatin | esophageal squamous cell carcinoma | Sensitive | High | 22847808 | |
| miR-923 | Cisplatin | Bladder Carcinoma | Sensitive | High | 22954303 | |
| miR-944 | Cisplatin | Bladder Carcinoma | Sensitive | High | 22954303 | |
| miR-942 | Cisplatin | ovarian cancer | Sensitive | High | 23045278 | |
| miR-99b* | Cisplatin | hepatocellular cancer | Sensitive | High | 23229111 | |
| miR-98 | Cisplatin | lung adenocarcinoma | Sensitive | Low | 23700794 | |
| miR-923 | Cisplatin | laryngeal cancer | Sensitive | High | 23780424 | |
| miR-93 | Cisplatin | laryngeal cancer | Sensitive | High | 23780424 | |
| miR-93* | Cisplatin | laryngeal cancer | Sensitive | High | 23780424 | |
| miR-920 | Cisplatin | squamous cell carcinoma | Sensitive | High | 23831023 | |
| miR-92b | Cisplatin | squamous cell carcinoma | Sensitive | High | 23831023 | |
| miR-98 | Cisplatin | squamous cell carcinoma | Resistant | High | 23831023 | |
| miR-92b | Cisplatin | non-small cell lung cancer | Resistant | Low | 24099768 | |
| miR-9 | Cisplatin | ovarian cancer | Sensitive | Low | 24168967 | |
| miR-98 | Cisplatin | ovarian cancer | Resistant | High | 24659709 | |
| miR-99a | Cisplatin | ovarian cancer | Sensitive | High | 24659709 | |
| miR-940 | Cisplatin | lung cancer | - | Low | 24675421 | |
| miR-92a | Cisplatin | esophageal squamous cell carcinoma | Sensitive | High | 25356050 | |
| miR-92b | Cisplatin | esophageal adenocarcinoma | Resistant | High | 25356050 | |
| miR-99b | Cisplatin | esophageal squamous cell carcinoma | Sensitive | High | 25356050 | |
| miR-96 | Cisplatin | esophageal cancer | Resistant | Low | 25465153 | |
| miR-93 | Cisplatin | ovarian cancer stem cells | Sensitive | Low | 25831546 | |
| miR-9 | Cisplatin | primary epithelial ovarian cancer | Sensitive | Low | 25846738 | |
| miR-933 | Cisplatin | ovarian cancer | Sensitive | High | 25872328 | |
| miR-96 | Cisplatin | ovarian cancer | Resistant | High | 25872328 | |
| miR-9 | Cisplatin | ovarian cancer | Resistant | High | 26043084 | |
| miR-98 | Cisplatin | ovarian cancer | Resistant | High | 26043084 | |
| miR-92a-1 | Cisplatin | small cell lung cancer | Resistant | High | 26676926 | |
| miR-92b | Cisplatin | small cell lung cancer | Resistant | High | 26676926 |